SCHEMBL3640263

SCHEMBL3640263

Cc1ccc(N2CCN(C(=O)C3CC(NCc4ccc(F)cc4F)CN3Cc3ccccc3)CC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 2/20 0.52
ACHE P22303 2/20 0.52
BACE1 P56817 2/20 0.52
GAA P10253 1/20 0.49
TP53 P04637 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTT P42858 1/20 0.42
MCHR1 Q99705 3/20 0.42
NPBWR1 P48145 2/20 0.42
KDM1A O60341 1/20 0.41
CHRM4 P08173 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
ALOX12 P18054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2820994 1.00 BCHE (0.52) BCHEACHEBACE1GAATP53
SCHEMBL2818844 0.95 BCHE (0.55) BCHEACHEBACE1GAATP53
SCHEMBL3641460 0.95 BCHE (0.55) BCHEACHEBACE1GAATP53
SCHEMBL3637560 0.94 BCHE (0.56) BCHEACHEBACE1GAATP53
SCHEMBL2817643 0.94 BCHE (0.56) BCHEACHEBACE1GAATP53
SCHEMBL2820908 0.92 BCHE (0.50) BCHEACHEBACE1GAATP53
SCHEMBL3974673 0.92 BCHE (0.50) BCHEACHEBACE1GAATP53
SCHEMBL3974947 0.92 BCHE (0.50) BCHEACHEBACE1GAATP53
SCHEMBL3643670 0.91 BCHE (0.49) BCHEACHEBACE1GAATP53
SCHEMBL2818184 0.91 BCHE (0.49) BCHEACHEBACE1GAATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155672-A1 PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS F. Hoffmann-Roche AG (CH) 2010-02-24 EP disclosed
WO-2008148689-A1 PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-12-11 WO disclosed